文献速递心境障碍

胼胝体下扣带回深部脑刺激治疗难治性抑郁的长期结局

Long-Term Outcomes of Subcallosal Cingulate Deep Brain Stimulation for Treatment-Resistant Depression.
PubMed 文献 · Am J Psychiatry · 2019-10-04

该开放标签长期随访研究纳入28例接受胼胝体下扣带回深部脑刺激(SCC DBS)的难治性抑郁患者(20例重性抑郁障碍、7例双相II型障碍,1例后重新分类),随访4-8年。结果显示应答率与缓解率在第2-8年分别维持≥50%和≥30%,四分之三参与者超过一半研究期内达到应答标准,21%自第一年起持续应答。手术总体安全耐受,无急慢性刺激副作用,无自杀事件。

要点

  • SCC DBS在4-8年随访中维持应答率≥50%、缓解率≥30%。
  • 21%患者自第一年起持续应答,四分之三超过一半研究期达到应答标准。
  • 手术安全耐受,并发症率与其他适应症DBS研究一致,无自杀事件。

核心结论

  • 在超过8年的观察中,多数接受SCC DBS的难治性抑郁患者获得了强健且持久的抗抑郁应答。

研究设计与样本

  • 开放标签长期随访设计,收集28例接受SCC DBS 4-8年的患者数据,其中20例重性抑郁障碍、7例双相II型障碍,1例重性抑郁亚组患者后重新分类为双相II型障碍。

主要发现

  • 应答率和缓解率在随访第2-8年分别维持≥50%和≥30%。
  • 四分之三的参与者在其参与研究期间超过一半的时间达到治疗应答标准。
  • 21%的患者自第一年起表现出持续治疗应答。
  • 28例中14例完成≥8年随访,11例完成≥4年,3例在8年前退出。
  • 手术总体安全耐受,无急性或慢性刺激副作用,无自杀事件。

关键数值与推荐

  • 应答率维持≥50%,缓解率维持≥30%,随访时间范围为第2-8年。
  • 医疗或手术并发症率与其他适应症DBS研究观察到的比率一致。

临床怎么用

  • 对于难治性抑郁患者,SCC DBS可能提供长期持久的抗抑郁应答,但需注意该研究为开放标签设计。

局限性

  • 开放标签设计,样本量较小(28例),部分患者退出或随访时间不足8年。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Deep brain stimulation of the subcallosal cingulate (SCC DBS) has been studied as a potential treatment for severe and refractory major depressive disorder since 2005. The authors used an open-label, long-term follow-up design to examine participants enrolled in a clinical trial of SCC DBS for treatment-resistant depression. METHODS: Long-term outcome data were collected for 28 patients (20 with major depressive disorder and seven with bipolar II disorder; one patient in the major depression subgroup was later reclassified as having bipolar II disorder) receiving SCC DBS for 4-8 years. RESULTS: Response and remission rates were maintained at ≥50% and ≥30%, respectively, through years 2-8 of the follow-up period. Three-quarters of all participants met the treatment-response criterion for more than half of their duration of participation in the study, with 21% of all patients demonstrating continuous response to treatment from the first year onward. Of 28 participants, 14 completed ≥8 years of follow-up, 11 completed ≥4 years, and three dropped out before 8 years. The procedure itself was generally safe and well tolerated, and there were no side effects of acute or chronic stimulation. The rate of medical or surgical complications was consistent with the rate observed in studies of DBS for other indications. There were no suicides. CONCLUSIONS: In >8 years of observation, most participants experienced a robust and sustained antidepressant response to SCC DBS.

来源:Am J Psychiatry,查看原文。版权归原作者所有。

引用

  1. Crowell AL, Riva-Posse P, Holtzheimer PE, et al. Long-Term Outcomes of Subcallosal Cingulate Deep Brain Stimulation for Treatment-Resistant Depression. Am J Psychiatry. 2019. PMID: 31581800. doi:10.1176/appi.ajp.2019.18121427

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。